funder-graph

FundersOK

Grants paid by Lmsarcoma Direct Research Foundation

EIN 87-0763851 · Tulsa, OK · Form 990, Schedule I · NTEE U50

Lmsarcoma Direct Research Foundation of Tulsa, OK (EIN 87-0763851) reported 13 grants paid totaling $715,391 to 12 recipients in tax years 2022–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.

Grants paid

$715,391

13 grants

Recipients

12

distinct organizations

Tax years

2022–2024

3 filings in the corpus

By tax year

Grants by tax year, as the same figures
Tax yearGrants paidAmount paidApproved for future
20226$213,391
20233$210,000
20244$292,000

Top recipients

The 12 recipients receiving the most from Lmsarcoma Direct Research Foundation, by grants paid, out of 12 distinct recipients.

Recipients ranked by total grants paid
RecipientMatchLocationGrantsTotal paidLatest year
Mcgill UniversityUMontreal, QUEBEC1$150,0002023
Research Institute Mcgill University Health Center 98-0031193AMontreal, Quebec1$150,0002024
City of HopeUDuarte, CA2$100,0002024
Ichon School of Medicine 13-6171197ANew York, NY1$67,0002024
Cedars Sinai 95-1644600ALos Angeles, CA1$50,0002022
Ichan School of MedicineUNew York, NY1$50,0002023
Sarcoma Alliance for Research CollaborationUAnn Arbor, MI1$50,0002022
Dana Farber Cancer Institute 04-2263040ABoston, MA1$38,6352022
Stanford University 94-1156365AStanford, CA1$25,0002024
Tatiana OmelchenkoUNew York, NY1$19,1382022
Sarc 86-1087705AAnn Arbor, MI1$10,0002023
The Rockefeller University 13-1624158BNew York, NY1$5,6182022

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Every grant

All 13 grant rows this organization reported, most recent first.

Grants reported by Lmsarcoma Direct Research Foundation
Tax yearRecipientMatchAmountTypePurposeSource filing
2024Research Institute Mcgill University Health Center Montreal, QuebecA$150,000paidResearch project "Multi Omic profiles and invasive properties of extracellular vesicles in Leiomyosarcoma"202621009349300947
2024Ichon School of Medicine New York, NYA$67,000paidBuild an integrated multi-omic + functional validation platform using patient-derived ULMS models to identify and validate therapeutic targets, then generalize findings using public ULMS datasets.202621009349300947
2024City of Hope Duarte, CAU$50,000paidExtension of grant made in 2022. Development of an Immune Biomarker for Metastatic Disease in Retroperitoneal Leiomyosarcoma (RP LMS).202621009349300947
2024Stanford University Stanford, CAA$25,000paidResearch regarding "Distribution of Novel Human Macrophage Subsets in LMS"202621009349300947
2023Mcgill University Montreal, QUEBECU$150,000paidMETABOLIC REPROGRAMING IN LEIOMYOSARCOMA (a multi year study)202443209349317749
2023Ichan School of Medicine New York, NYU$50,000paidLeiomyosarcoma Cancer Research202443209349317749
2023Sarc Ann Arbor, MIA$10,000paidSponsorship supports investigator travel, follow up meetings for present and future Researchers. SARC is a 501C3 organization.202443209349317749
2022City of Hope Duarte, CAU$50,000paidOngoing LMS research conducted by Dr. William Tseng.202303119349302860
2022Cedars Sinai Los Angeles, CAA$50,000paidCancer research.202303119349302860
2022Sarcoma Alliance for Research Collaboration Ann Arbor, MIU$50,000paidCancer research202303119349302860
2022Dana Farber Cancer Institute Boston, MAA$38,635paidCancer research202303119349302860
2022Tatiana Omelchenko New York, NYU$19,138paidCancer research.202303119349302860
2022The Rockefeller University New York, NYB$5,618paidCancer research.202303119349302860

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Source filings

Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.

Returns this page is derived from
FormTax yearPeriod endFiledSchemaIRS OBJECT_ID
99020242024-12-31not stated2024v5.0202621009349300947
99020232023-12-31not stated2023v5.0202443209349317749
99020222022-12-31not stated2022v5.0202303119349302860

Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/870763851.json.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.